We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$905M
AUM Growth
-$6.65M
Cap. Flow
+$9.3M
Cap. Flow %
1.03%
Top 10 Hldgs %
52.46%
Holding
657
New
198
Increased
119
Reduced
86
Closed
223

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$67.4M
2
PFE icon
Pfizer
PFE
+$65.6M
3
APTV icon
Aptiv
APTV
+$29.7M
4
MRNA icon
Moderna
MRNA
+$22.6M
5
CRM icon
Salesforce
CRM
+$19.6M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$85.2M
2
RUN icon
Sunrun
RUN
+$64.1M
3
TPIC
TPI Composites
TPIC
+$31.4M
4
MSFT icon
Microsoft
MSFT
+$30.9M
5
AMZN icon
Amazon
AMZN
+$30.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.6%
2 Healthcare 14.17%
3 Technology 11.37%
4 Financials 4.47%
5 Communication Services 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCTR icon
226
Victory Capital Holdings
VCTR
$6.84B
$449K 0.05%
12,818
– –
HGV icon
227
Hilton Grand Vacations
HGV
$3.31B
$443K 0.05%
+9,317
New +$395K
PRU icon
228
Prudential Financial
PRU
$41.9B
$442K 0.05%
+4,201
New +$433K
CCRN
229
DELISTED
Cross Country Healthcare
CCRN
$436K 0.05%
20,529
– –
TPL icon
230
Texas Pacific Land
TPL
$24.2B
$435K 0.05%
3,240
+477
+17% +$74.2K
ATLC icon
231
Atlanticus Holdings
ATLC
$1.47B
$431K 0.05%
+8,118
New +$396K
EVRI
232
DELISTED
Everi Holdings
EVRI
$429K 0.05%
17,731
+710
+4% +$16.2K
RITM icon
233
Rithm Capital
RITM
$5.59B
$429K 0.05%
+39,023
New +$401K
CLX icon
234
Clorox
CLX
$13B
$428K 0.05%
2,584
+1,466
+131% +$252K
OLN icon
235
Olin
OLN
$2.13B
$428K 0.05%
+8,879
New +$414K
PANW icon
236
Palo Alto Networks
PANW
$312B
$426K 0.05%
5,340
-1,248
-19% -$87.7K
ERII icon
237
Energy Recovery
ERII
$413M
$423K 0.05%
+22,251
New +$452K
MRCY icon
238
Mercury Systems
MRCY
$6.52B
$423K 0.05%
+8,929
New +$496K
BOOT icon
239
Boot Barn
BOOT
$5.12B
$418K 0.05%
+4,704
New +$405K
VXX icon
240
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$146M
$417K 0.05%
938
+625
+200% +$280K
PRKS icon
241
United Parks & Resorts
PRKS
$2.07B
$412K 0.05%
+7,443
New +$375K
EBF icon
242
Ennis
EBF
$559M
$411K 0.05%
21,785
+7,168
+49% +$141K
HRB icon
243
H&R Block
HRB
$5.86B
$410K 0.05%
16,381
-4,210
-20% -$105K
SNX icon
244
TD Synnex
SNX
$20.5B
$410K 0.05%
+3,935
New +$471K
EW icon
245
Edwards Lifesciences
EW
$53.2B
$408K 0.05%
3,604
-614
-15% -$70.1K
XOM icon
246
ExxonMobil
XOM
$659B
$408K 0.05%
6,931
-3,199
-32% -$182K
INTC icon
247
Intel
INTC
$498B
$407K 0.05%
7,638
+3,140
+70% +$170K
ZD icon
248
Ziff Davis
ZD
$1.99B
$406K 0.04%
3,416
-925
-21% -$111K
HCSG icon
249
Healthcare Services Group
HCSG
$1.51B
$404K 0.04%
+16,149
New +$437K
IPAR icon
250
Interparfums
IPAR
$3.78B
$403K 0.04%
+5,395
New +$394K
8 9
10
11 12

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q3 2021 Portfolio in Review

As of Q3 2021, Caxton Associates (New York) held 657 positions worth $905M, down 0.73% from $912M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Caxton Associates (New York)'s Q3 2021 filing shows 198 new, 119 increased, 86 reduced and 223 closed positions. Its largest new stake was Pfizer: 1,480,000 shares worth $63.7M. The largest sale was Baidu, an estimated $85.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • Caxton Associates (New York)'s largest Q3 2021 buy was Pfizer: 1,480,000 shares worth $63.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2021, an estimated $67.4M increase.
  • Caxton Associates (New York)'s biggest Q3 2021 reduction was Sunrun, cutting an estimated $64.1M.
  • Caxton Associates (New York) fully exited Baidu in Q3 2021, selling an estimated $85.2M.
  • Caxton Associates (New York)'s ten largest holdings make up 52% of its $905M portfolio in Q3 2021.
  • Caxton Associates (New York) opened 198 new positions and closed 223 in Q3 2021.
  • Caxton Associates (New York)'s portfolio value fell 0.73% quarter-over-quarter to $905M.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.